SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-14-441178
Filing Date
2014-12-12
Accepted
2014-12-12 15:14:08
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d837003dsc14d9.htm SC 14D9 487017
2 EX-99.A.9 d837003dex99a9.htm EX-99.A.9 4896
3 EX-99.E.17 d837003dex99e17.htm EX-99.E.17 311928
4 GRAPHIC g837003g44u48.jpg GRAPHIC 7366
5 GRAPHIC g837003g84l26.jpg GRAPHIC 10566
  Complete submission text file 0001193125-14-441178.txt   830826
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filed by) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Subject) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 14D9 | Act: 34 | File No.: 005-41430 | Film No.: 141283414
SIC: 2834 Pharmaceutical Preparations